References
- Abraham RE, Alghazwi M, Liang Q, Zhang W. 2021. Advances on marine-derived natural radioprotection compounds: historic development and future perspective. Oral Oncology. 3:474–487.
- Feng X, Li Y, Zhang L, Sun H, Liu S. 2023. Fucoxanthin inhibits the proliferation and stem cell formation of oral squamous cell carcinoma (OSCC) cells by regulating JAK/STAT3 pathway. Oral Oncology. 22:9–14.
- Gutiérrez-Rodríguez AG, Juarez-Portilla C, Olivares-Banuelos T, Zepeda RC. 2018. Anticancer activity of seaweeds. Oral Oncology. 23:434–447.
- Mabrouk AA, El-Mezayen NS, Awaad AK, Tadros MI, El-Gazayerly ON, El-Refaie WM. 2023. Novel celecoxib-loaded chitosan-fucoidan nanoparticles as potential immunotherapy for oral squamous cell carcinoma: mechanistic insights. Oral Oncology. 81:104228.
- Tagliapietra BL, Clerici MTPS. 2023. Brown algae and their multiple applications as functional ingredient in food production. Oral Oncology. 167:112655.
- Yang CH, Chang YC, Hsu CC, Lin CH, Chen IJ, Wu YT, Lan YY. 2023. Fucoidan enhances cisplatin-induced effects on SCC-25 human oral cancer cells by inhibiting the PI3K/AKT pathway. Oral Oncology. 43:4015–4022.
- Zubair T, Bandyopadhyay D. 2023. Small molecule EGFR inhibitors as anti-cancer agents: discovery, mechanisms of action, and opportunities. Oral Oncology. 24:2651.